Health financing in response to COVID-19: An agenda for research by Barasa, Edwine et al.
 





Health Financing in Response to 
Covid-19:  An Agenda For 
Research 
 
12th December 2020 
 
 
2 | P a g e  
 
  
Suggested Citation. Barasa E, Bennett S, Rao K, Goodman C, Gupta I, Hanvoravongchai P, 
James C, Maceira D, Witter S, Hanson K. 2020.  
Health financing in response to COVID-19:  An agenda for research. [Working paper – HSG web 
reference] 
 
1 KEMRI-Wellcome Trust Research Programme, Kenya 
2 Johns Hopkins Bloomberg School of Public Health, USA 
3 London School of Hygiene and Tropical Medicine, UK 
4 Institute of Economic Growth, India 
5 Faculty of Medicine, Chulalongkorn University, Thailand 
6 OECD, Paris 
7 University of Buenos Aires, Argentina 
8 Queen Margaret University Edinburgh, UK 
 
Barasa E1, Bennett S2, Rao K2, Goodman C3, Gupta I4, Hanvoravongchai P5, James C6, 
Maceira D7, Witter S8, Hanson K3. 
 
Health Financing in Response to Covid-19:  
An Agenda For Research 
 
 
3 | P a g e  
 
Abstract  
The global spread of COVID-19 has affected both the health and economic condition of countries, with 
major health system impacts.  There has been an immediate need to invest in clinical services to treat 
patients and mount an effective public health response, requiring substantial increases in health 
spending.  But the impact of the pandemic on the global economy also raises challenges for future 
health spending, with potential impacts on commitments to universal health coverage.  In this working 
paper we outline a broad research agenda that would help countries deal with the health financing 
challenges they are facing, and emerge from the COVID-19 crisis with stronger health financing 
systems.  While recognising that research priorities must be tailored to the needs of specific countries, 
we argue there is much to be gained by starting from a common agenda, which could enable a 
coordinated approach and maximise the potential for cross-country comparative work. Such a body 
of research will enable lessons to be drawn for (i) managing the current crisis; (ii) ensuring resilience 
of health systems to future shocks; and (iii) enhancing medium-term progress towards UHC.  
  
 




The global spread of COVID-19 has affected both the health and economic condition of countries.  In 
low- and middle- income countries (LMICs), where health resources were already scarce, policy 
makers face unprecedented difficulties in financing health. Even relatively affluent countries have 
faced major financing challenges, with governments having to rapidly pivot resources, and bring in 
extra protections for groups at risk of financial hardship while seeking care for COVID-19, with mixed 
success. 
The pandemic has necessitated major health system responses.  All countries have needed to invest 
more in their health care systems, including procuring ventilators, oxygen, and personal protective 
equipment; scaling up COVID-19 testing; building and equipping new temporary health care facilities 
or reconfiguring existing facilities; setting up virtual systems for service provision; and reimbursing 
and incentivizing health workers to work extra hours under challenging conditions. In addition, public 
health services have been ramped up, as countries have sought to establish new cadres of health 
workers responsible for contact tracing and quarantine enforcement, as well as the provision of 
information to the general public and the oversight of infection control measures in public and private 
spaces. Beyond these health investments, there has been a need to finance the public health-related 
response of other sectors, from supporting COVID-19 related controls at borders to providing 
adequate food supplies to communities under lockdown and reorienting the education system to 
manage remote learning. Going forward, financing of vaccine delivery will be an important priority for 
national governments. In this paper, we focus on financing the health system, broadly conceived to 
include both the provision of health care and public health functions. 
While the need for additional resources to finance new services is the most obvious demand that 
COVID-19 places on health financing, there are at least two other important dimensions to this issue.  
First, the COVID-19 pandemic has clearly brought in its wake a massive, global economic recession. It 
is estimated as of October 2020 that the global economy will shrink by 4.4% in 20201, with as many as 
100 million people pushed into poverty2, and the ILO has warned that the pandemic has severely 
threatened the livelihoods of many outside the formal sector, estimating that 1.6 billion informal 
sector workers globally may lose their livelihoods due to COVID-193. This economic impact undermines 
health financing systems by reducing the income households have available to pay for health care 
services, and, for systems financed by health insurance premium contributions, reducing the number 
of people contributing to risk pools and (depending on scheme design) the number of people covered 
by health insurance.   While government spending on health has significantly increased in 2020, 
financed by a combination of borrowing and quantitative easing, it is unclear how long such increases 
can be sustained with government revenues curtailed due to recession.  
Second, it seems likely that progress on the historic global commitments to universal health coverage4 
(UHC) may be undermined by the pandemic. For obvious reasons the attention of health policymakers 
has pivoted towards COVID-19 and this, combined with the global recession, may hamper progress 
along the path to UHC.  Conversely, the pandemic could provide a window of opportunity to accelerate 
UHC progress, by highlighting existing limitations in the financing of public health and community 
health care, vividly demonstrating the relevance of health to the national and global economy, and 
generally raising the profile of health on the policy agenda and highlighting the synergies between 
solidarity and health security.  
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Purpose 
The purpose of this paper is to take a first step in outlining a broad research agenda that would help 
countries deal with the health financing challenges they are facing, and emerge from the COVID-19 
crisis with stronger health financing systems. While valuable exercises have been undertaken to define 
COVID-19 research priorities in general5,6, and for health policy and systems research7, we believe this 
is the first systematic identification of health financing research questions for the COVID-19 era.  
Clearly, priorities for research vary across and within countries, depending on the design of the health 
system, its wider context and the underlying values that it reflects, making it extremely challenging to 
develop a universal set of priorities. However, we argue that there is much to be gained by scoping 
out the broad range of relevant questions that can then be tailored to each setting. We hope that by 
making this thinking explicit, public and open for comment we can promote discussion, solicit 
additional ideas, stimulate high quality research and funding for this area, and through a coordinated 
approach, maximise the potential for cross-country comparative work. Such a body of research will 
enable lessons to be drawn for (i) managing the current crisis; (ii) ensuring resilience of health systems 
to future shocks; and (iii) enhancing medium-term progress towards UHC. 
The ideas presented below emerged from a series of discussions, initially between a small group of 
researchers (in universities and research institutes), health financing advisors (at the World Bank, the 
World Health Organization, and OECD) and research advisors (at the Alliance for Health Policy and 
Systems Research). Subsequently, a broader group of researchers were engaged with a primary aim 
of ensuring that this document was informed by diverse country perspectives. While the paper builds 
upon our knowledge of the existing literature it has not benefitted from a systematic review, nor 
consultative processes within individual countries8. 
We have sought to identify research priorities that may be relevant to low and middle-income 
countries, though many will also apply to high income settings. While the questions may be relevant 
to the sub-national, national, regional and global levels, our primary focus is on the financing of 
country health systems as opposed to, for example, financing research and development for new 
vaccines. 
This paper is structured around the following four themes: 
A. Resource mobilization required for the health system to respond to COVID-19, and be 
prepared for future epidemics; 
B. Resource allocation and purchasing processes to effectively and efficiently manage the 
response to COVID-19 and to future epidemics; 
C. Protecting people from health-related financial hardship and the exacerbation of inequities in 
the context of COVID-19 and its aftermath; 
D. Sustaining and enabling continued progress towards UHC.  
 
For each theme, we summarise the current context and key developments, and then identify a set of 
related research questions. Implicit in the specified research questions is a recognition of the value of 
comparative analyses that allow us to understand how different country health financing systems, or 
different responses during the epidemic, have influenced outcomes. 
Resource mobilization  
Country governments have had to mobilize significant additional resources to finance the COVID-19 
response. For example, in the US, the government through the CARES Act provided an additional 
US$175 billion for hospitals and health care providers9, and India established the PM CARES fund to 
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channel national and foreign donations and government money to the pandemic response10.   
Increased spending on COVID-19 has been financed in part by reallocations within existing budget 
envelopes – with spending shifting across budget lines, both within the health sector and from other 
sectors – and in part by additional aggregate spending11.  The latter has been facilitated by higher fiscal 
deficits (few governments have sought to raise resource from increased taxation, at least not yet) 
which in turn are financed from: (i) drawing on reserves; (ii) higher government borrowing, from 
domestic financial markets (supported by loosening of monetary policy and QE); and (iii) from external 
sources, both private capital markets (mainly in middle-income countries) and from international 
financial institutions  and development partners. The ease with which spending can be reallocated will 
depend on public finance regulation:  in some countries it is relatively easy to move funding across 
government budget lines, while this is much harder in other contexts12.  
For many LMICs, development partner funding may be a significant component of the overall 
response. The West Africa Ebola virus epidemic in 2014 stimulated international organizations to 
establish separate funding pots for such outbreaks, including the Pandemic Emergency Financing Fund 
(PEF) at the World Bank and the Pandemic Financing Facility at the International Monetary Fund. The 
PEF, in particular its insurance window component,  has however has been controversial: established 
as a public/private partnership with support from private reinsurance firms and backing from select 
high income countries, during the current pandemic pay-outs have been criticized for being too little 
and too late, and the World Bank has decided against issuing further pandemic financing bonds13, 
illustrating the ongoing need for better global financing to support country level efforts.  
Country governments may also be experimenting with innovative sources of domestic financing, such 
as government guarantees for private sector investment in COVID-19 test manufacturing capacity14, 
but this has not been systematically documented, nor are there current data that reveal the relative 
importance of public and private sources of finance in battling the pandemic. While data are scarce, 
it appears that typically countries are mobilizing resources from multiple sources, leaving open 
questions about the fragmentation and lack of coordination of health financing mechanisms for 
COVID-19, and potential negative effects on equity between geographical areas and socio-economic 
groups. This may particularly occur in decentralized contexts where local authorities pursue their own 
strategies to raise resources, as well as receiving funding from the national level.  
Preliminary research questions identified 
i. How have country governments increased health expenditure for the COVID-19 response, 
including through reallocating resources from other sectors to health, reallocations within the 
health sector, and supplemental budgets? Where governments have increased overall 
expenditure, how has this been financed (increased taxes, debt financing, or monetary financing 
of the deficit)? 
ii. How effective have existing pandemic global financing mechanisms been in terms of resource 
mobilization, disbursement, and their influence on country responses to COVID-19?  
iii. What have been the relative roles of government and private sources of financing for COVID-19 
and non-COVID health services during the pandemic period, and how successful has this financing 
profile been in mobilizing resources? 
iv. To what extent have public financial management regulations facilitated or constrained 
reallocation across government budget lines?   
v. To what extent have resource generation been coordinated across different levels and agencies 
(eg. between government budgets and social health insurance agencies, and between central and 
sub-national levels) versus exacerbating fragmentation in mobilization and allocation of resources 
for health? 
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vi. How will the contraction in national economies and knock-on effects on total public spending 
affect future resources for health?  
 
Allocation and purchasing 
Countries have needed to make rapid decisions about which COVID-19 interventions to purchase, 
from who, and how, while also continuing to support general essential health services. Early in the 
pandemic countries struggled with procuring sufficient quantities of personal protective equipment 
for healthcare settings and scaling capacity for advanced critical care from basic items such as oxygen 
and pulse oxymeters)15,16 and new intensive care units and additional ventilators. Other questions 
about purchasing have focussed on the extent to which existing financing systems supported the 
purchase of digital or virtual health services. Many countries (for example, Indonesia, Japan, Korea 
and the US) had policies that prevented public health insurance schemes from reimbursing patients 
for health services received virtually17,18, but many of these rules were rapidly changed. In several 
instances, governments have stepped in to regulate private insurance schemes with the aim of 
ensuring that they take steps to improve the affordability of diagnostics and treatment19. 
One critical area in terms of purchasing concerns support to public health. The relatively successful 
containment of the epidemic in many Asian countries is likely explained in part by effective and well-
funded public health systems that rapidly scaled up control methods such as surveillance, contact 
tracing, border controls and quarantine20. Funding for essential public health functions is often 
strongly debated and uncertain, with countries under-investing in public health during ‘normal’ years 
and then being inadequately equipped to deal with emergencies. There is also debate about whether 
resources for public health functions should be channeled  through ministries of health (where it may 
be prioritized but disconnected from other sectors) or through local government (where it may be 
deprioritized)21.  
In many cases, in order to rapidly scale up response to COVID-19, health authorities have sought to 
purchase services from the private sector, including both the direct purchase of health services from 
private hospitals (as under the Ayushman Bharat scheme in India22) and various non-clinical services 
(for example, the use of school and hotel buildings for isolation and quarantine).  In some cases, this 
has involved considerable change and innovation in how private providers have been selected and 
contracts negotiated, and little is known about the efficiency, quality and equity implications of such 
purchases.  
Besides making decisions about what to purchase, there are also important questions about the 
efficiency of spending during the pandemic. There are many examples of competition driving up the 
price of essential supplies which have affected government authorities, health care providers and 
consumers23. In some cases, regulatory agencies have intervened to prevent price hikes24 and enforce 
quality standards.  But rapid procurement also led to allegations of corruption25, raising questions 
about how procurement regulations to protect against corruption and other poor practices have been 
adapted to facilitate more rapid purchasing. The implications of this for accountability, quality and 
efficiency have yet to be explored.  
Preliminary research questions identified 
i. How have benefit packages and services purchased by government authorities changed during 
the pandemic (including entitlements, services included, and rationing mechanisms) and what 
factors have driven these prioritization decisions?  
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ii. How have purchasing, payment and accreditation mechanisms been changed in response to 
COVID-19 for both publicly and privately provided services, and how have these performed? 
iii. How have public health interventions (e.g. surveillance, contract tracing, border controls) been 
financed and organized during the pandemic, and what are the implications for longer term 
policy?  
iv. How will governments finance purchase of vaccines, and prioritise groups to receive a vaccine 
once it becomes available?  
v. How have existing financing arrangements in a country, and their associated purchasing practices, 
enabled or disabled an effective response? For example, to what extent have challenges arisen 
due to multiple overlapping schemes focused on the same population, or fragmented patient 
information systems? 
vi. In terms of public financial management, what adaptations and work-arounds have been made to 
budgeting, procurement, payment management etc. to facilitate rapid responses to COVID-19?  
What is known about the transparency and accountability of public funds used in the COVID-19 
response, and how have changes to allocation and purchasing /procurement processes affected 
this?   
Financial risk protection and equity  
A key health system goal is providing financial protection and equity in service use.  Globally, 12.7% of 
households incurred catastrophic health spending in 201526.  Even in countries with well-established 
systems of financial protection, all citizens are not well-covered; for example, in Brazil, China and 
Singapore the share of out-of-pocket payments in total health spending is 27%, 36% and 32%, 
respectively27.   
Providing financial protection to households becomes all the more important in the time of epidemics 
like COVID-19. COVID-19 patients can experience increased household health expenditures because 
of payments for consultations, diagnostics, drugs, and hospitalization. Yet some national systems 
exclude vulnerable populations such as migrants, refugees, and people employed in the informal 
sector.  Many of these groups are at heightened risk of COVID-19 given their employment and living 
conditions.  Some governments, such as that in Singapore, have pro-actively reached out to such 
groups seeking to improve both the services they have access to and their living conditions28, after a 
major outbreak highlighted systematic neglect in the past29. COVID-19 has also exposed the limitations 
of health financing systems which link entitlement to contributions, and which rely on employment-
based contributions as a funding source.  However, countries face challenges in expanding tax-based 
financing systems at a time of overall greater financial need and dwindling resources.  
In addition to direct healthcare expenditure, COVID-19 patients are also likely to experience 
productivity losses due to days of lost work and job losses due to the economic shock triggered by 
COVID, and may feel compelled to adopt risky coping strategies at household level. Mortality of 
earning family members due to COVID-19 will also have devastating effects on the financial well-being 
of households. 
Further, financial barriers often deter patients from seeking the health care they need and increase 
inequities in access for vulnerable groups. Faced with high costs of health services, many COVID-19 
patients might choose to forego treatment, exposing them to the possibility of prolonged illness or 
even death. Equity of utilization for COVID and non-COVID related care may also be affected by non-
financial factors, such a concern about COVID-19 infection risk, social stigma and lockdown policies. 
Understanding how governments can continue to provide, or increase, financial protection and equity 
of health care access for vulnerable populations is therefore crucial. 
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Preliminary research questions Identified 
i. How has use of COVID-19 services and public and private expenditure on these varied across 
vulnerable groups (by gender, ethnicity, age, socio-economic status, location, and health status)?  
What is the socioeconomic distribution of public subsidies for these services? 
ii. How has use of and spending on non-COVID-19 related services changed during the epidemic and 
how has this varied across vulnerable groups? Have there been explicit efforts to protect funding 
for facilities / services used mainly by the poor and vulnerable? 
iii. How have COVID-19-specific services- such as testing, isolation or quarantine, case management 
(institutional or home based), and death related expenses - been paid for, and to what extent have 
different groups experienced catastrophic health expenditures or impoverishment as a result?  
iv. Have financing arrangements reinforced pooling arrangements (for example, by bringing in 
previously uncovered groups) or undermined them (through increased fragmentation).   
v. Have public safety nets (health-related or more general social protection schemes) protected 
vulnerable households from health-related costs? 
vi. What have been the productivity losses experienced by households due to COVID-19 illness and 
lockdown measures across vulnerable groups? 
vii. How has the economic recession affected care seeking, insurance coverage, and financial 
protection of individuals? 
Sustaining and enabling progress towards UHC 
Prior to the current pandemic, many countries had made important commitments towards achieving 
UHC. These commitments took the form of global agreements such as the UN Political Declaration on 
UHC30, aligned to SDG 3.8, as well as individual country commitments, such as the launch of the 
Ayushman Bharat scheme in India31, or the National Health Insurance policy in South Africa32. There 
are a number of reasons why the COVID-19 pandemic may affect - both positively and negatively - 
these commitments. The pandemic implies two significant shocks for the health system including, first, 
substantive new demands upon the health system and a need to reallocate resources rapidly to deal 
with the pandemic, and second, the global recession that will strain fiscal space, reduce the proportion 
of the population in formal sector employment, and possibly erode financial support for UHC. 
However, crises such as the COVID-19 pandemic can also stimulate innovations that may support 
progress to UHC, from the adoption of digital technologies, to streamlined procurement systems, 
greater intersectoral collaboration, and the extension of free health care services to marginalized 
populations. The crisis could potentially also alter the set of fiscal policy options considered, for 
example, creating policy windows to consider new taxes, such as on sugar sweetened beverages, 
tobacco or alcohol. More generally, the crisis may create opportunities for greater political support 
for solidarity in health care financing, and greater attention to health security, nationally and globally.   
 
In understanding the implications of the economic recession for the UHC agenda, there is a prior 
literature that may yield insights. For example, a recent review found evidence of governments 
withdrawing from UHC commitments when financial austerity measures were put in place33. Counter 
examples exist, however; to provide one instance, some of the key Thai health financing reforms were 
put in place in the wake of the 1997 Asian Economic crisis34. In general, policy analysis theories point 
to the importance of windows of opportunity that may be created by elections, conflict or pandemics 
and economic recession35. What we understand less are the factors that determine whether countries 
are able to take advantage of such policy windows in ways that move the UHC agenda forward, though 
the nature of the political settlement, country capacity, and coherence of international support are 
likely important influences36,37. 
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One element that will likely affect the future of UHC reforms in the post-pandemic world is the extent 
to which policy and decision-makers see UHC as a package of policy solutions comprising not just the 
financing of individual health care services but also a strong public health system with effective 
surveillance and response capacities, versus seeing these as two competing agendas. UHC advocates 
will likely need a strong understanding of how politicians are framing these ideas in order to target 
advocacy efforts effectively. 
Even more broadly, analysis of health system resilience will assist in the design of health systems able 
to withstand shocks whilst preserving core functions. Documenting the health financing arrangements 
different countries have employed to address COVID-19, how these new measures were agreed, 
coordinated and implemented, and the effects that they have had on health outcomes, financial 
protection and the health system more broadly, offers a means to better understand what it takes for 
health financing systems to be truly resilient38. 
Preliminary research questions Identified 
i. How has the pandemic and subsequent reallocation of resources affected country level plans and 
processes for expanding UHC? 
ii. Looking to the future, how can national health services or insurance programs seek to sustain pre-
COVID levels of health care financing in the face of economic recession? 
iii. To what extent has the COVID-19 pandemic changed the political economy of health financing 
policy discussions, in terms of the acceptability of different fiscal policy options, pooling and 
purchasing mechanisms, and the framing and importance attached to health and UHC?  
iv. What lessons can be drawn from the COVID-19 experience to inform the future design of health 
financing arrangements in ways that enable greater health system resilience, including capacity 
for pandemic response, and how do these vary across country contexts (for example, high income 
versus LMICs, and more stable versus those already fragile and shock-prone before COVID-19)? 
 
Conclusion  
COVID-19 presents a unique challenge for health financing both because of the size and scale of its 
impact on the health sector as well as its significant economic ramifications at national and global 
levels. Evidence on the impact of COVID-19 on health financing, as well as the adaptations that 
different countries have made to health financing systems to accommodate this impact, is needed to 
both inform ongoing measures to fight the pandemic as well as to ensure long-term planning for future 
pandemics and greater resilience within health financing systems.  
We have outlined starting points for a research agenda for health financing for COVID-19, identifying 
a preliminary set of priority questions addressing four thematic areas, namely resource mobilization, 
allocation and purchasing, financial risk protection and equity, and sustaining and enabling progress 
for UHC.  Each question would require further elaboration and unpacking, with development of 
appropriate research approaches using a mixture of quantitative and qualitative methods. While there 
is clearly a need for tailoring of research questions and country-specific analyses to inform local 
decision-making, there will also be great value in larger cross-country comparative research initiatives 
to address these questions, allowing learning about how different systems, contexts, values and 
responses to the epidemic have shaped health financing outcomes and how these can be 
strengthened. 
While the research questions identified are mainly empirical in nature, we also encourage the health 
financing community to reflect on how the pandemic may challenge our current framing of health 
financing debates, and the frameworks and paradigms that we use. For example, should we rethink 
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the boundaries of the “health system”, or move toward frameworks that integrate health and broader 
social protection? 
We hope that this paper will stimulate policy makers, researchers and development partners to 
discuss these suggested research questions within their communities, and contribute to further 
developing this agenda – please comment on our blog post at www..********, or contact us directly 
with your additions or critiques. Next steps should include (i) the development of programmes of 
research to address country-specific priorities and provide scope for common research across 
countries; (ii) development of funding modalities to ensure this agenda is well-supported, and (iii) 
establishment of a platform and community to share research approaches and results, and enable 
comparative analysis to identify lessons learnt. COVID-19 has hugely challenged our health financing 
systems, and illuminated the fault lines in the health sector, but it also provides opportunities for 
innovation, reflection and advocacy, and the potential to ensure health systems are better prepared 
for future crises and reinvigorated in the journey towards UHC.  
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